Patent · US Active

Allergen

US10753946B2 · kind B2 · utility

0Cited by

2References

14Claims

0Family size

Assignee

PHADIA AB · SE

Inventors

Lars Mattsson · Uppsala, SE
Ulrica Olsson · Uppsala, SE
Thomas Lundgren · Uppsala, SE
Jonas Lidholm · Knivsta, SE
Håkan LARSSON · Göteborg, SE

Key dates

Filing date	Jul 20, 2015
Grant date	Aug 25, 2020
Priority date	—
Expiry date	Apr 22, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/47
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a novel horse allergen consisting of a heterodimeric protein having a first peptide chain and a second peptide chain together having an overall sequence identity of at least 70% with the combined sequences of SEQ ID NO:3 and SEQ ID NO: 4, as well as a single chain protein having an overall sequence identity of at least 70%, such as 75%, 80%, 85%, 90%, 95%, or 98%, with the combined amino acid sequences according to SEQ ID NO: 3 and SEQ ID NO: 4. The invention further relates to the use of the protein in methods of diagnosis and therapy of Type I allergy, and kits and compositions for use in such methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.